Defining the minimally effective dose and schedule for parenteral hydrogen sulfide: long-term benefits in a rat model of hindlimb ischemia

BACKGROUND: Peripheral arterial disease (PAD) affects millions of Americans and leads to critical limb ischemia (CLI) in the most severe cases. Investigators have demonstrated the utility of hydrogen sulfide for restoring perfusion in rodent models of chronic ischemia. We sought to determine the min...

Descripción completa

Detalles Bibliográficos
Autores principales: Langston, John William, Toombs, Christopher F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410454/
https://www.ncbi.nlm.nih.gov/pubmed/25918638
http://dx.doi.org/10.1186/s13618-015-0027-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410454/
https://www.ncbi.nlm.nih.gov/pubmed/25918638
http://dx.doi.org/10.1186/s13618-015-0027-1

Ejemplares similares